Similar articles

• Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.

  Brown MP, Coy DH, Gomez-Pan A, Hirst BH, Hunter M, Meyers C, Reed JD, Schally AV, Shaw B. Brown MP, et al. J Physiol. 1978 Apr;277:1-14. doi: 10.1113/jphysiol.1978.sp012256. J Physiol. 1978. PMID: 349135 Free PMC article.
• [Somatostatin and inhibition of gastric acid secretion].

  Puşcaş I. Puşcaş I. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1978 Mar-Apr;30(2):113-6. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1978. PMID: 26949 Review. Romanian. No abstract available.
• Structure-activity studies with somatostatin: the role of tryptophan in position 8.

  Hirst BH, Shaw B, Meyers CA, Coy DH. Hirst BH, et al. Regul Pept. 1980 Oct;1(2):97-113. doi: 10.1016/0167-0115(80)90014-2. Regul Pept. 1980. PMID: 6114515
• Subcutaneous administration of somatostatin analogs as a major factor in the enhancement of the duration of action.

  Torchiana ML, Cook PG, Wiese SR, Saperstein R, Veber DF. Torchiana ML, et al. Arch Int Pharmacodyn Ther. 1978 Sep;235(1):170-6. Arch Int Pharmacodyn Ther. 1978. PMID: 736688
• [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].

  Lankosz-Lauterbach J. Lankosz-Lauterbach J. Pediatr Pol. 1977 Aug;52(8):919-23. Pediatr Pol. 1977. PMID: 333364 Review. Polish. No abstract available.